Literature DB >> 25006715

Affinity-based precipitation via a bivalent peptidic hapten for the purification of monoclonal antibodies.

Michael W Handlogten1, Jared F Stefanick, Peter E Deak, Basar Bilgicer.   

Abstract

In a previous study, we demonstrated a non-chromatographic affinity-based precipitation method, using trivalent haptens, for the purification of mAbs. In this study, we significantly improved this process by using a simplified bivalent peptidic hapten (BPH) design, which enables facile and rapid purification of mAbs while overcoming the limitations of the previous trivalent design. The improved affinity-based precipitation method (ABP(BPH)) combines the simplicity of salt-induced precipitation with the selectivity of affinity chromatography for the purification of mAbs. The ABP(BPH) method involves 3 steps: (i) precipitation and separation of protein contaminants larger than immunoglobulins with ammonium sulfate; (ii) selective precipitation of the target-antibody via BPH by inducing antibody-complex formation; (iii) solubilization of the antibody pellet and removal of BPH with membrane filtration resulting in the pure antibody. The ABP(BPH) method was evaluated by purifying the pharmaceutical antibody trastuzumab from common contaminants including CHO cell conditioned media, DNA, ascites fluid, other antibodies, and denatured antibody with >85% yield and >97% purity. Importantly, the purified antibody demonstrated native binding activity to cell lines expressing the target protein, HER2. Combined, the ABP(BPH) method is a rapid and scalable process for the purification of antibodies with the potential to improve product quality while decreasing purification costs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25006715     DOI: 10.1039/c4an00780h

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

Review 1.  Extracellular vesicle isolation and characterization: toward clinical application.

Authors:  Rong Xu; David W Greening; Hong-Jian Zhu; Nobuhiro Takahashi; Richard J Simpson
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

2.  Heparin affinity purification of extracellular vesicles.

Authors:  Leonora Balaj; Nadia A Atai; Weilin Chen; Dakai Mu; Bakhos A Tannous; Xandra O Breakefield; Johan Skog; Casey A Maguire
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.